← Leaderboards
Fang Xinping
Xenobiotic Laboratories, Inc.
$2,258,161
Attributed
$2,258,161
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $733.4K · FY2013–18$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,258,161 · 1
By mechanism
N01$2,258,161 · 1
Top collaborators
No co-investigators on record.
Most similar at Xenobiotic Laboratories, Inc.
Same institution · by research overlap
- Dennis Heller$281,991
- Xin Zhang$131,331
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsProgram DevelopmentServicesDrug Of AbuseProteinsContractsPeptidesSmall MoleculeResearch And DevelopmentBiological MarkersPerformanceChemistryResourcesMolecularOutcome MeasurePharmacotherapyPlasmaPreclinical StudyProceduresPublishingSalivaSpecimenTherapy DevelopmentTissues
Grant awards (6)
IGF::OT::IGF : TASK ORDER 10. ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM. SEPTEMBER 15, 2013 - SEPTEMBER 14, 2018. N01DA-13-8920.PURPOSE: TO EXTEND THE PERIOD OF PERFORMANCE FOR$8,361
N01 · FY2018 · DA · contact PI
IGF::OT::IGF : Analytical Services Center for Medications Development Program. September 15, 2013 - September 14, 2018. N01DA-13-8920.PURPOSE: To obligate funds to fully fund performance under T$278,157
N01 · FY2017 · DA · contact PI
IGF::OT::IGF : Analytical Services Center for Medications Development Program. September 15, 2013 - September 14, 2018. N01DA-13-8920.PURPOSE: To obligate funds to fully fund performance under T$633,945
N01 · FY2016 · DA · contact PI
Analytical Services Center for Medications Development Program$322,774
N01 · FY2015 · DA · contact PI
Analytical Services Center for Medications Development Program$733,449
N01 · FY2014 · DA · contact PI
Analytical Services Center for Medications Development Program$281,475
N01 · FY2013 · DA · contact PI